NCT02316483View on ClinicalTrials.gov

Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions
Charcot ArthropathyType 2 Diabetes
Trial Locations (1)

Unknown

Hamad Medical Corporation, Doha

Sponsors

Collaborators (1)

Hamad Medical Corporation
All Listed Sponsors
collaborator

Hamad Medical Corporation

INDUSTRY

collaborator

Weill Cornell Medical College in Qatar

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT02316483 - Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes | Biotech Hunter | Biotech Hunter